A New Decision Tree Combining Abeta 1-42 and p-Tau Levels in Alzheimer's Diagnosis

By  

Current Alzheimer Research, Vol. 10, Iss. 4, 2013-05 ,pp. : 357-364

Bentham Science Publishers

Access to resources Recommend Favorite

Neurodegenerative disease biomarkers Aβ_1–40, Aβ_1–42, tau, and p‐tau₁₈₁ in the vervet monkey cerebrospinal fluid: Relation to normal aging, genetic influences, and cerebral amyloid angiopathy

By  

Brain And Behavior, Vol. 8, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cerebrospinal fluid levels of phosphorylated tau and Aβ1-38/Aβ1-40/Aβ1-42 in Alzheimer's disease with PS1 mutations

By Ikeda Masaki  

Amyloid: The Journal of Protein Folding Disorders, Vol. 20, Iss. 2, 2013-06 ,pp. : 107-112

Informa Healthcare

Access to resources Recommend Favorite

CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer’s disease

By Toledo Jon   Korff Ane   Shaw Leslie   Trojanowski John   Zhang Jing  

Acta Neuropathologica, Vol. 126, Iss. 5, 2013-11 ,pp. : 683-697

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of CSF-Chlamydia pneumoniae, CSF-tau, and CSF-Abeta42 in Alzheimer’s disease and vascular dementia

By Paradowski Bogusław   Jaremko Malgorzata   Dobosz Tadeusz   Leszek Jerzy   Noga Leszek  

Journal of Neurology, Vol. 254, Iss. 2, 2007-02 ,pp. : 154-159

Springer Publishing Company

Access to resources Recommend Favorite